Dexcom (Nasdaq:DXCM) today unveiled its next-generation continuous glucose monitor (CGM), the G8 system, at its Investor Day ...

Glooko announced that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform.

Glooko and MyLife Diabetes Care announced today that they agreed to expand their partnership centered around diabetes ...

ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in ...

Sava Technologies today announced the appointment of John Bernard as its new chief commercial officer (CCO).

Senseonics (NYSE:SENS) today reported first-quarter financial results that exceeded Wall Street's revenue expectations.

Tandem Diabetes Care (Nasdaq:TNDM) today shared first-quarter financial results that came in ahead of the consensus forecast ...

Glucotrack (Nasdaq:GCTK) announced today that it submitted its implantable continuous blood glucose monitor (CBGM) for FDA ...

Blood glucose monitoring company LifeScan announced today that it appointed Jonathan Salkin as its new CEO, effective ...